These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 11245391)

  • 21. Effects of postnatal dexamethasone exposure on the developmental outcome of premature infants.
    Needelman H; Evans M; Roberts H; Sweney M; Bodensteiner JB
    J Child Neurol; 2008 Apr; 23(4):421-4. PubMed ID: 18079310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lower gastrointestinal tract perforation in preterm infants treated with dexamethasone for bronchopulmonary dysplasia.
    Ng PC; Fok TF; So KW; Wong W; Yip PK; Liu K
    Pediatr Surg Int; 1997 Feb; 12(2-3):211-2. PubMed ID: 9156866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlled trial of dexamethasone in neonatal chronic lung disease: an 8-year follow-up of cardiopulmonary function and growth.
    Mieskonen S; Eronen M; Malmberg LP; Turpeinen M; Kari MA; Hallman M
    Acta Paediatr; 2003 Aug; 92(8):896-904. PubMed ID: 12948063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postnatal hydrocortisone treatment for chronic lung disease in the preterm newborn and long-term neurodevelopmental follow-up.
    Rademaker KJ; de Vries LS; Uiterwaal CS; Groenendaal F; Grobbee DE; van Bel F
    Arch Dis Child Fetal Neonatal Ed; 2008 Jan; 93(1):F58-63. PubMed ID: 17848504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of surfactant treatment in preterm infants and term newborns with acute respiratory distress syndrome.
    Wirbelauer J; Speer CP
    J Perinatol; 2009 May; 29 Suppl 2():S18-22. PubMed ID: 19399004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postnatal dexamethasone for lung disease of prematurity.
    Watchko JF; Brozanski BS
    N Engl J Med; 2004 Jun; 350(26):2715-8; author reply 2715-8. PubMed ID: 15218577
    [No Abstract]   [Full Text] [Related]  

  • 27. Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus.
    Fujii AM; Brown E; Mirochnick M; O'Brien S; Kaufman G
    J Perinatol; 2002; 22(7):535-40. PubMed ID: 12368968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Respiratory burst activity in bronchopulmonary dysplasia and changes with dexamethasone.
    Ballabh P; Simm M; Kumari J; Califano C; Aghai Z; Laborada G; Sison C; Cunningham-Rundles S
    Pediatr Pulmonol; 2003 May; 35(5):392-9. PubMed ID: 12687597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome at 2 years of age of infants from the DART study: a multicenter, international, randomized, controlled trial of low-dose dexamethasone.
    Doyle LW; Davis PG; Morley CJ; McPhee A; Carlin JB;
    Pediatrics; 2007 Apr; 119(4):716-21. PubMed ID: 17403842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repeat surfactant therapy for postsurfactant slump.
    Katz LA; Klein JM
    J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dexamethasone therapy in neonates treated with extracorporeal membrane oxygenation.
    Griffin MP; Wooldridge P; Alford BA; McIlhenny J; Ksenich RA
    J Pediatr; 2004 Mar; 144(3):296-300. PubMed ID: 15001930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levels of evidence for the pharmacological effectiveness of prolonged methylprednisolone treatment in unresolving acute respiratory distress syndrome.
    Meduri GU
    Minerva Anestesiol; 1999 May; 65(5):193-6. PubMed ID: 10389390
    [No Abstract]   [Full Text] [Related]  

  • 33. Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants.
    Rozycki HJ; Byron PR; Elliott GR; Carroll T; Gutcher GR
    Pediatr Pulmonol; 2003 May; 35(5):375-83. PubMed ID: 12687595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneous localized intestinal perforation and intestinal dilatation in very-low-birthweight infants.
    Koshinaga T; Gotoh H; Sugito K; Ikeda T; Hagiwara N; Tomita R
    Acta Paediatr; 2006 Nov; 95(11):1381-8. PubMed ID: 17062464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Follow-up of a randomized, placebo-controlled trial of dexamethasone to decrease the duration of ventilator dependency in very low birth weight infants: neurodevelopmental outcomes at 4 to 11 years of age.
    O'Shea TM; Washburn LK; Nixon PA; Goldstein DJ
    Pediatrics; 2007 Sep; 120(3):594-602. PubMed ID: 17766533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reopening the debate on corticosteroids: to the editor.
    Gordon PV
    Pediatrics; 2006 Jun; 117(6):2318-20; author reply 2320. PubMed ID: 16740883
    [No Abstract]   [Full Text] [Related]  

  • 37. New insights into spontaneous intestinal perforation using a national data set (3): antenatal steroids have no adverse association with spontaneous intestinal perforation.
    Attridge JT; Clark R; Gordon PV
    J Perinatol; 2006 Nov; 26(11):667-70. PubMed ID: 17024144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of ductal closure and intestinal complications in very low birth weight infants treated with indomethacin.
    Madan J; Fiascone J; Balasubramanian V; Griffith J; Hagadorn JI
    Neonatology; 2008; 94(1):45-51. PubMed ID: 18196930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The DART study of low-dose dexamethasone therapy.
    Rademaker KJ; Groenendaal F; van Bel F; de Vries LS; Uiterwaal CS
    Pediatrics; 2007 Sep; 120(3):689-90; author reply 690-1. PubMed ID: 17766548
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevention of necrotizing enterocolitis in preterm infants: a 20-year experience.
    Pietz J; Achanti B; Lilien L; Stepka EC; Mehta SK
    Pediatrics; 2007 Jan; 119(1):e164-70. PubMed ID: 17145901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.